首页 > 最新文献

International Journal of Hypertension最新文献

英文 中文
Platelet Indices and Hypertension: Results from Shahedieh Cohort Study, Yazd, Iran 血小板指数与高血压:伊朗亚兹德沙赫迪耶队列研究的结果
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2024-02-13 DOI: 10.1155/2024/3705771
Fateme Shakeri Shamsi, Moslem Taheri Soodejani
Introduction. Hypertension is one of the most important diseases worldwide. In this study, we aim to demonstrate the relationship between platelet indices and hypertension. Materials and Methods. We studied 9448 people in the age range of 30 to 70 years. We assessed their hypertension status, platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), smoking, cardiovascular disease history, diabetes status, body mass index, and creatinine levels. Hypertension status was assessed qualitatively. All platelet indices were categorized by quartiles. We then used logistic regression to predict the relationship between these indices and hypertension. Results. PDW index and hypertension had a statistically significant relationship in the second quartile (16.2 fL < PDW ≤ 16.7 fL) in 30 to 40 years old (AOR: 0.225, 95% CI: 0.063–0.806), in the fourth quartile in 50 to 60 years old (AOR = 1.532, 95% CI: 1.048–2.238), and in all the quartiles of the age range of over 60 years. PLT index had a positive relationship (AOR = 3.147, 0.95% CI: 1.163–8.516) in 30 to 40 years old in the fourth quartile vs. the first quartile. A positive relationship was obtained in the third and fourth quartiles of PLT and the age range of 40 to 50 years, respectively (AOR = 2.063, 0.95% CI: 1.162–3.662) and (AOR = 2.204, 0.95% CI: 1.220–3.981). Conclusion. According to the results of this study, some platelet indices could be correlated with hypertension, so we may be able to reduce the burden of this disease.
引言高血压是全球最重要的疾病之一。本研究旨在证明血小板指数与高血压之间的关系。材料和方法。我们对 9448 名年龄介于 30 岁至 70 岁之间的人进行了研究。我们评估了他们的高血压状况、血小板计数(PLT)、血小板平均体积(MPV)、血小板分布宽度(PDW)、吸烟、心血管疾病史、糖尿病状况、体重指数和肌酐水平。对高血压状况进行了定性评估。所有血小板指数均按四分位数分类。然后,我们使用逻辑回归法预测这些指数与高血压之间的关系。结果PDW 指数与高血压的关系在统计学上有显著意义:30 至 40 岁的第二四分位数(16.2 fL < PDW ≤ 16.7 fL)(AOR:0.225,95% CI:0.063-0.806),50 至 60 岁的第四四分位数(AOR = 1.532,95% CI:1.048-2.238),以及 60 岁以上的所有四分位数。与第一四分位数相比,PLT 指数在 30-40 岁的第四四分位数中呈正相关(AOR = 3.147,0.95% CI:1.163-8.516)。PLT的第三和第四四分位数与40至50岁年龄段分别存在正相关关系(AOR = 2.063,0.95% CI:1.162-3.662)和(AOR = 2.204,0.95% CI:1.220-3.981)。结论根据这项研究的结果,一些血小板指数可能与高血压相关,因此我们或许可以减轻这种疾病的负担。
{"title":"Platelet Indices and Hypertension: Results from Shahedieh Cohort Study, Yazd, Iran","authors":"Fateme Shakeri Shamsi, Moslem Taheri Soodejani","doi":"10.1155/2024/3705771","DOIUrl":"https://doi.org/10.1155/2024/3705771","url":null,"abstract":"<i>Introduction</i>. Hypertension is one of the most important diseases worldwide. In this study, we aim to demonstrate the relationship between platelet indices and hypertension. <i>Materials and Methods</i>. We studied 9448 people in the age range of 30 to 70 years. We assessed their hypertension status, platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), smoking, cardiovascular disease history, diabetes status, body mass index, and creatinine levels. Hypertension status was assessed qualitatively. All platelet indices were categorized by quartiles. We then used logistic regression to predict the relationship between these indices and hypertension. <i>Results</i>. PDW index and hypertension had a statistically significant relationship in the second quartile (16.2 fL &lt; PDW ≤ 16.7 fL) in 30 to 40 years old (AOR: 0.225, 95% CI: 0.063–0.806), in the fourth quartile in 50 to 60 years old (AOR = 1.532, 95% CI: 1.048–2.238), and in all the quartiles of the age range of over 60 years. PLT index had a positive relationship (AOR = 3.147, 0.95% CI: 1.163–8.516) in 30 to 40 years old in the fourth quartile vs. the first quartile. A positive relationship was obtained in the third and fourth quartiles of PLT and the age range of 40 to 50 years, respectively (AOR = 2.063, 0.95% CI: 1.162–3.662) and (AOR = 2.204, 0.95% CI: 1.220–3.981). <i>Conclusion</i>. According to the results of this study, some platelet indices could be correlated with hypertension, so we may be able to reduce the burden of this disease.","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"18 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139753230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation of Brain Oxidative Stress in the DOCA-Salt Hypertensive Rats 大川芎煎剂通过减轻 DOCA 盐高血压大鼠脑氧化应激改善钠敏感性和血浆去甲肾上腺素水平
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2024-02-02 DOI: 10.1155/2024/2226143
Qi Zhang, Hao Li, Shan Zhao, Fangfang Li, Yingying Tan
Background. Da-Chuan-Xiong Decoction (DCXD) is an aqueous extract from a classic Chinese herbal formula composed of dried rhizomes of Ligusticum chuanxiong Hort and Gastrodia elata Bl. in the mass ratio of 4 : 1. It has been long used to treat chronic cardiovascular disease caused by blood stasis and wind pathogen in the clinic. This experimental study aimed to investigate the blood pressure (BP)-lowering effect of DCXD treatment on hypertension and underlying mechanisms. Methods. Male Sprague–Dawley rats were used in the experiment, and the hypertensive models were created by administering deoxycorticosterone acetate (DOCA) in conjunction with a high salt intake in uninephrectomized rats. DCXD was administered to hypertensive rats by oral gavage daily at a dose of 5 g/kg or 2.5 g/kg bodyweight for 28 days. The brain sodium sensitivity, ENaC function, superoxide anion level, NADPH oxidase activity, and expression of ENaC, p67phox, p47phox, and Rac1 in the paraventricular nucleus were assessed by using the appropriate methods. Results. The 28 days of DCXD (5 g/kg) treatment significantly reduced the increased BP effectively, inhibited the enhanced heart index, kidney index, and 24 h urinary protein, and improved the progressive pathological changes of heart and kidney, which was comparable to that of the positive control amlodipine. DCXD treatment also caused a marked reduction in plasma norepinephrine and induced a significant improvement in brain sodium sensitivity and ENaC function in DOCA-salt hypertensive rats. Rats in DCXD-treated groups also exhibited decreased superoxide anion levels and NADPH oxidase activity in the paraventricular nucleus. The level of ENaC, p67phox, and Rac1 protein expression in the paraventricular nucleus was significantly downregulated by DCXD treatment in DOCA-salt hypertensive rats. Conclusions. These findings indicate that the depressor action and sympathetic inhibition of DCXD on salt-sensitive hypertension may be by ameliorating brain sodium sensitivity, modulating ENaC function, and inhibiting the expression of ENaC and NADPH oxidase in the hypothalamic paraventricular nucleus.
背景介绍大川芎煎剂(DCXD)是从经典中药配方中提取的水提取物,由川芎和天麻的干燥根茎组成,质量比为 4 :1.长期以来,临床上一直用于治疗血瘀风邪引起的慢性心血管疾病。本实验研究旨在探讨天麻素治疗高血压的降压效果及其机制。方法:雄性 Sprague-Dawley 大鼠。实验采用雄性 Sprague-Dawley 大鼠,通过对未切除肾脏的大鼠在高盐摄入的同时给予醋酸去氧皮质酮(DOCA)来建立高血压模型。高血压大鼠每天口服 5 克/千克或 2.5 克/千克体重的 DCXD,持续 28 天。采用适当的方法评估脑钠敏感性、ENaC功能、超氧阴离子水平、NADPH氧化酶活性以及脑室旁核中ENaC、p67phox、p47phox和Rac1的表达。结果28天的DCXD(5 g/kg)治疗能有效降低血压升高,抑制心脏指数、肾脏指数和24 h尿蛋白的升高,改善心脏和肾脏的进行性病理改变,其效果与阳性对照氨氯地平相当。DCXD 还能明显降低 DOCA 盐高血压大鼠的血浆去甲肾上腺素,显著改善脑钠敏感性和 ENaC 功能。DCXD 处理组大鼠室旁核的超氧阴离子水平和 NADPH 氧化酶活性也有所下降。DCXD 处理后,DOCA-盐高血压大鼠室旁核的 ENaC、p67phox 和 Rac1 蛋白表达水平显著下调。结论这些研究结果表明,DCXD 对盐敏感性高血压的抑制作用和交感神经抑制可能是通过改善脑钠敏感性、调节 ENaC 功能以及抑制下丘脑室旁核 ENaC 和 NADPH 氧化酶的表达实现的。
{"title":"Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation of Brain Oxidative Stress in the DOCA-Salt Hypertensive Rats","authors":"Qi Zhang, Hao Li, Shan Zhao, Fangfang Li, Yingying Tan","doi":"10.1155/2024/2226143","DOIUrl":"https://doi.org/10.1155/2024/2226143","url":null,"abstract":"<i>Background</i>. Da-Chuan-Xiong Decoction (DCXD) is an aqueous extract from a classic Chinese herbal formula composed of dried rhizomes of Ligusticum chuanxiong Hort and <i>Gastrodia elata</i> Bl. in the mass ratio of 4 : 1. It has been long used to treat chronic cardiovascular disease caused by blood stasis and wind pathogen in the clinic. This experimental study aimed to investigate the blood pressure (BP)-lowering effect of DCXD treatment on hypertension and underlying mechanisms. <i>Methods</i>. Male Sprague–Dawley rats were used in the experiment, and the hypertensive models were created by administering deoxycorticosterone acetate (DOCA) in conjunction with a high salt intake in uninephrectomized rats. DCXD was administered to hypertensive rats by oral gavage daily at a dose of 5 g/kg or 2.5 g/kg bodyweight for 28 days. The brain sodium sensitivity, ENaC function, superoxide anion level, NADPH oxidase activity, and expression of ENaC, p67phox, p47phox, and Rac1 in the paraventricular nucleus were assessed by using the appropriate methods. <i>Results</i>. The 28 days of DCXD (5 g/kg) treatment significantly reduced the increased BP effectively, inhibited the enhanced heart index, kidney index, and 24 h urinary protein, and improved the progressive pathological changes of heart and kidney, which was comparable to that of the positive control amlodipine. DCXD treatment also caused a marked reduction in plasma norepinephrine and induced a significant improvement in brain sodium sensitivity and ENaC function in DOCA-salt hypertensive rats. Rats in DCXD-treated groups also exhibited decreased superoxide anion levels and NADPH oxidase activity in the paraventricular nucleus. The level of ENaC, p67phox, and Rac1 protein expression in the paraventricular nucleus was significantly downregulated by DCXD treatment in DOCA-salt hypertensive rats. <i>Conclusions</i>. These findings indicate that the depressor action and sympathetic inhibition of DCXD on salt-sensitive hypertension may be by ameliorating brain sodium sensitivity, modulating ENaC function, and inhibiting the expression of ENaC and NADPH oxidase in the hypothalamic paraventricular nucleus.","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"9 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139661924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Antihypertensive Drug-Related Gene Polymorphisms with Stroke in the Chinese Hypertensive Population 中国高血压人群中抗高血压药物相关基因多态性与脑卒中的关系
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2024-01-23 DOI: 10.1155/2024/5528787
Huixia Liu, Hua Zhong, Ying Lin, Linzhi Han, Mengshi Chen, Tao Tang, Jing Deng
Background. Antihypertensive therapy is crucial for preventing stroke in hypertensive patients. However, the efficacy of antihypertensive therapy varies across individuals, partially due to therapy-related genetic variations among individuals. We investigated the association of antihypertensive drug-related gene polymorphism with stroke in patients with hypertension. Methods. Demographic information, medication, and outcome data were obtained from a hypertensive patient management system, and a PCR fluorescence probe technique was used to detect 7 gene polymorphic loci (CYP2D610, ADRB1, CYP2C93, AGTR1, ACE, CYP3A53, and NPPA), and these loci were compared between patients with and without stroke. Logistic regression was performed to analyze the association of these genetic variations with stroke risk in hypertensive patients while controlling for potential factors. Results. The prevalence of stroke in the hypertensive population in Changsha County of Hunan Province was 2.75%. The mutation frequencies of ADRB1 (1165G > C), CYP2D610, CYP2C93, AGTR1 (1166A > C), ACE (I/D), NPPA (2238T > C), and CYP3A5
背景。降压治疗对预防高血压患者中风至关重要。然而,抗高血压治疗的疗效因人而异,部分原因是个体间存在与治疗相关的基因变异。我们研究了抗高血压药物相关基因多态性与高血压患者中风的关系。研究方法利用 PCR 荧光探针技术检测 7 个基因多态性位点(CYP2D610、ADRB1、CYP2C93、AGTR1、ACE、CYP3A53 和 NPPA)。在控制潜在因素的情况下,对这些基因变异与高血压患者中风风险的关系进行了逻辑回归分析。结果显示湖南省长沙县高血压人群的脑卒中发病率为 2.75%。ADRB1(1165G >;C)、CYP2D610、CYP2C93、AGTR1(1166A >;C)、ACE(I/D)、NPPA(2238T >;C)和 CYP3A53 的突变频率分别为 74.43%、57.23%、4.26%、5.71%、31.62%、1.17% 和 69.58%。单变量分析显示,ADRB1 多态性与脑卒中相关(χ2 = 8.659,),CC 组的脑卒中风险高于 GC 组和 GG 组(GC + GG)。多变量无条件逻辑回归分析显示,ADRB1 的 CC 基因型(与 GC + GG 基因型相比)与高血压患者中风风险的增加有关[几率比(OR)= 1.184,P<0.05]。在 CYP2D610、CYP2C93、AGTR1 (1166A > C)、ACE (I/D)、CYP3A53 和 NPPA (2238T > C) 多态性与中风之间未观察到任何关联。结论ADRB1(1165G >C)基因多态性与中国高血压患者的中风风险有关。与 GC + GG 基因型相比,CC 基因型与中风风险相关性更高。
{"title":"Association of Antihypertensive Drug-Related Gene Polymorphisms with Stroke in the Chinese Hypertensive Population","authors":"Huixia Liu, Hua Zhong, Ying Lin, Linzhi Han, Mengshi Chen, Tao Tang, Jing Deng","doi":"10.1155/2024/5528787","DOIUrl":"https://doi.org/10.1155/2024/5528787","url":null,"abstract":"<i>Background</i>. Antihypertensive therapy is crucial for preventing stroke in hypertensive patients. However, the efficacy of antihypertensive therapy varies across individuals, partially due to therapy-related genetic variations among individuals. We investigated the association of antihypertensive drug-related gene polymorphism with stroke in patients with hypertension. <i>Methods</i>. Demographic information, medication, and outcome data were obtained from a hypertensive patient management system, and a PCR fluorescence probe technique was used to detect 7 gene polymorphic loci (<i>CYP2D6</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"></path></g></svg><i>10</i>, <i>ADRB1</i>, <i>CYP2C9</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"><use xlink:href=\"#g113-43\"></use></g></svg><i>3</i>, <i>AGTR1</i>, <i>ACE</i>, <i>CYP3A5</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"><use xlink:href=\"#g113-43\"></use></g></svg><i>3</i>, and <i>NPPA</i>), and these loci were compared between patients with and without stroke. Logistic regression was performed to analyze the association of these genetic variations with stroke risk in hypertensive patients while controlling for potential factors. <i>Results</i>. The prevalence of stroke in the hypertensive population in Changsha County of Hunan Province was 2.75%. The mutation frequencies of <i>ADRB1</i> (<i>1165G</i> &gt; <i>C</i>), <i>CYP2D6</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"><use xlink:href=\"#g113-43\"></use></g></svg><i>10</i>, <i>CYP2C9</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><g transform=\"matrix(.013,0,0,-0.013,0,0)\"><use xlink:href=\"#g113-43\"></use></g></svg><i>3</i>, <i>AGTR1</i> (<i>1166A</i> &gt; <i>C</i>), <i>ACE</i> (<i>I</i>/<i>D</i>), <i>NPPA</i> (<i>2238T</i> &gt; <i>C</i>), and <i>CYP3A5</i><svg height=\"6.01072pt\" style=\"vertical-align:-0.04980993pt\" version=\"1.1\" viewbox=\"-0.0498162 -5.96091 7.75925 6.01072\" width=\"7.75925pt\" xmlns=\"http://www.w3.org/2000/svg\" xml","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"4 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139560646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Link between Overweight/Obesity and Noncommunicable Diseases in Ethiopia: Evidences from Nationwide WHO STEPS Survey 2015. 埃塞俄比亚超重/肥胖与非传染性疾病之间的联系:来自2015年全国世卫组织STEPS调查的证据
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-11-16 eCollection Date: 2023-01-01 DOI: 10.1155/2023/2199853
Bedilu Alamirie Ejigu, Fentanesh Nibret Tiruneh

Background: Noncommunicable diseases (NCDs) are the leading cause of death worldwide. Each year, 15 million adults die from NCDs; more than 85% of these premature deaths occur in low- and middle-income nations. Evidence indicates that overweight and obesity are the main risk factors for NCDs. Although the literature indicates that the burden of NCDs is increasing in Ethiopia, no research has been conducted to demonstrate a link between overweight/obesity and NCDs. Therefore, the aim of this study is to examine the association between overweight/obesity and the common NCDs while adjusting for other important factors.

Methods: We analysed data from the 2015 Ethiopia WHO STEPS survey, which was conducted in 2015. A total weighted sample of 9,800 participants (15-69 years) was included. The relationship between nutritional status and NCDs was assessed using bivariate and multivariable logistic regression models while adjusting for covariates.

Results: Among the 9,800 participants, 2053 (21% with (95% CI: 19.8-22.1) had hypertension and 1368 (14% with (95% CI: 13.1-15.0) had high cholesterol levels. According to the multivariable logistic regression analysis, being overweight/obese (AOR = 2.0; 95% CI: 1.7-2.3), alcohol consumption, received lifestyle advice, being female, living in urban areas, increased age, having government occupation, and living in SNNP region were positively associated with hypertension. While being underweight (AOR = 0.6; 95% CI: 0.5-0.7), living in the Afar, Somali, and Tigray regions were negatively associated with hypertension. Being overweight/obese (AOR = 1.4; 95% CI: 1.1-1.7), being female, having older age, and living in Somali region were positively associated with a high cholesterol level. Whereas being underweight (AOR = 0.7; 95% CI: 0.6-0.9), received lifestyle advice, reside in rural areas, being farmer, student, and housewife, and living in Gambela region were negatively associated with a high cholesterol level.

Conclusion: This study found a statistically positive association between the common NCDs, namely, overweight/obesity, hypertension, and high cholesterol levels. Our findings imply that there is a need for effective interventions to prevent overweight/obesity by encouraging people to increase physical activity, minimize sedentary behavior, and maintain a healthy dietary pattern in order to reduce the risk of hypertension and high cholesterol levels.

背景:非传染性疾病(NCDs)是世界范围内导致死亡的主要原因。每年有1500万成年人死于非传染性疾病;这些过早死亡中85%以上发生在低收入和中等收入国家。有证据表明,超重和肥胖是非传染性疾病的主要危险因素。尽管文献表明埃塞俄比亚的非传染性疾病负担正在增加,但尚未开展研究证明超重/肥胖与非传染性疾病之间存在联系。因此,本研究的目的是在调整其他重要因素的同时,研究超重/肥胖与常见非传染性疾病之间的关系。方法:分析2015年埃塞俄比亚世卫组织STEPS调查数据。总加权样本包括9800名参与者(15-69岁)。在调整协变量的同时,使用双变量和多变量逻辑回归模型评估营养状况与非传染性疾病之间的关系。结果:在9800名参与者中,2053名(21%,95% CI: 19.8-22.1)患有高血压,1368名(14%,95% CI: 13.1-15.0)患有高胆固醇水平。根据多变量logistic回归分析,超重/肥胖(AOR = 2.0;95% CI: 1.7-2.3)、饮酒、接受生活方式建议、女性、居住在城市地区、年龄增加、从事政府工作和居住在SNNP地区与高血压呈正相关。体重过轻时(AOR = 0.6;95%可信区间:0.5-0.7),生活在阿法尔、索马里和提格雷地区与高血压呈负相关。超重/肥胖(AOR = 1.4;95% CI: 1.1-1.7)、女性、年龄较大、生活在索马里地区与高胆固醇水平呈正相关。而体重过轻(AOR = 0.7;95% CI: 0.6-0.9)、接受生活方式建议、居住在农村地区、是农民、学生和家庭主妇以及居住在甘贝拉地区与高胆固醇水平负相关。结论:本研究发现常见的非传染性疾病,即超重/肥胖、高血压和高胆固醇水平之间存在统计学上的正相关。我们的研究结果表明,有必要通过鼓励人们增加体育活动、减少久坐行为和保持健康的饮食模式来预防超重/肥胖,以降低高血压和高胆固醇水平的风险。
{"title":"The Link between Overweight/Obesity and Noncommunicable Diseases in Ethiopia: Evidences from Nationwide WHO STEPS Survey 2015.","authors":"Bedilu Alamirie Ejigu, Fentanesh Nibret Tiruneh","doi":"10.1155/2023/2199853","DOIUrl":"https://doi.org/10.1155/2023/2199853","url":null,"abstract":"<p><strong>Background: </strong>Noncommunicable diseases (NCDs) are the leading cause of death worldwide. Each year, 15 million adults die from NCDs; more than 85% of these premature deaths occur in low- and middle-income nations. Evidence indicates that overweight and obesity are the main risk factors for NCDs. Although the literature indicates that the burden of NCDs is increasing in Ethiopia, no research has been conducted to demonstrate a link between overweight/obesity and NCDs. Therefore, the aim of this study is to examine the association between overweight/obesity and the common NCDs while adjusting for other important factors.</p><p><strong>Methods: </strong>We analysed data from the 2015 Ethiopia WHO STEPS survey, which was conducted in 2015. A total weighted sample of 9,800 participants (15-69 years) was included. The relationship between nutritional status and NCDs was assessed using bivariate and multivariable logistic regression models while adjusting for covariates.</p><p><strong>Results: </strong>Among the 9,800 participants, 2053 (21% with (95% CI: 19.8-22.1) had hypertension and 1368 (14% with (95% CI: 13.1-15.0) had high cholesterol levels. According to the multivariable logistic regression analysis, being overweight/obese (AOR = 2.0; 95% CI: 1.7-2.3), alcohol consumption, received lifestyle advice, being female, living in urban areas, increased age, having government occupation, and living in SNNP region were positively associated with hypertension. While being underweight (AOR = 0.6; 95% CI: 0.5-0.7), living in the Afar, Somali, and Tigray regions were negatively associated with hypertension. Being overweight/obese (AOR = 1.4; 95% CI: 1.1-1.7), being female, having older age, and living in Somali region were positively associated with a high cholesterol level. Whereas being underweight (AOR = 0.7; 95% CI: 0.6-0.9), received lifestyle advice, reside in rural areas, being farmer, student, and housewife, and living in Gambela region were negatively associated with a high cholesterol level.</p><p><strong>Conclusion: </strong>This study found a statistically positive association between the common NCDs, namely, overweight/obesity, hypertension, and high cholesterol levels. Our findings imply that there is a need for effective interventions to prevent overweight/obesity by encouraging people to increase physical activity, minimize sedentary behavior, and maintain a healthy dietary pattern in order to reduce the risk of hypertension and high cholesterol levels.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"2199853"},"PeriodicalIF":1.9,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138459862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary Consequences of Blood Pressure Management and Blood Homocysteine Levels with Perindopril in Newly Diagnosed Hypertensive Patients in the Vietnamese Population. 在越南人群中,新诊断的高血压患者使用培哚普利进行血压管理和血液同型半胱氨酸水平的初步后果。
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-10-18 eCollection Date: 2023-01-01 DOI: 10.1155/2023/1933783
Son Kim Tran, An Bao Truong, Phi Hoang Nguyen, Toan Hoang Ngo, Tuyen Long Vu, Khoa Dang Dang Tran, Phuong Minh Vo, Bao The Nguyen, Tuong Le Trong Huynh, Kien Trung Nguyen, Hung Do Tran

Background: Perindopril is an ACE inhibitor that aids in both blood pressure regulation and homocysteine reduction.

Objectives: Our study aimed to evaluate the results of controlling blood pressure and blood homocysteine levels by perindopril in patients with primary hypertension.

Materials and methods: A cross-sectional descriptive study with a longitudinal follow-up was conducted on 105 primary hypertensive patients treated with perindopril.

Results: The results of our study showed that after 6 weeks of treatment with perindopril, the proportion of patients with the target blood pressure (BP) level accounted for 70.5%, the rate of grade 1 hypertension decreased from 61.0% to 25.7%, grade 2 blood pressure decreased from 17.1% to 3.8%, and there was no case of grade 3 hypertension. At the same time, we also found that the rate of BP control in the group of patients who controlled Hcy below a threshold of 15 μmol/L was significantly higher than in the other group (p  <  0.05). Concerning the efficacy of decreasing homocysteine in blood, we discovered that after 6 weeks of treatment with perindopril, the proportion of patients with elevated homocysteine reduced considerably from 74.3% to 40% (p  <  0.05). In addition, the homocysteine concentration was 4.33 mol/L lower after treatment than before treatment (95% CI: 3.69-4.97) (p  <  0.05).

Conclusion: Perindopril helps control blood pressure and reduces blood homocysteine levels in patients with primary hypertension.

背景:培哚普利是一种ACE抑制剂,有助于调节血压和降低同型半胱氨酸。目的:本研究旨在评价培哚普利控制原发性高血压患者血压和血液同型半胱氨酸水平的效果。材料和方法:对105例接受培哚普利治疗的原发性高血压患者进行横断面描述性研究和纵向随访。结果:我们的研究结果表明 培哚普利治疗周,达到目标血压(BP)水平的患者比例占70.5%,1级高血压发生率从61.0%下降到25.7%,2级高血压从17.1%下降到3.8%,无3级高血压病例。同时,我们还发现,在将Hcy控制在阈值15以下的患者组中,BP控制率 μmol/L显著高于对照组(p  <  0.05)。关于降低血液中同型半胱氨酸的疗效,我们发现在6 培哚普利治疗数周后,同型半胱氨酸升高的患者比例从74.3%显著降低到40%(p  <  0.05)。此外,同型半胱氨酸浓度为4.33 mol/L治疗后低于治疗前(95%可信区间:3.69~4.97)(p  <  结论:培哚普利有助于控制原发性高血压患者的血压,降低血液同型半胱氨酸水平。
{"title":"Preliminary Consequences of Blood Pressure Management and Blood Homocysteine Levels with Perindopril in Newly Diagnosed Hypertensive Patients in the Vietnamese Population.","authors":"Son Kim Tran,&nbsp;An Bao Truong,&nbsp;Phi Hoang Nguyen,&nbsp;Toan Hoang Ngo,&nbsp;Tuyen Long Vu,&nbsp;Khoa Dang Dang Tran,&nbsp;Phuong Minh Vo,&nbsp;Bao The Nguyen,&nbsp;Tuong Le Trong Huynh,&nbsp;Kien Trung Nguyen,&nbsp;Hung Do Tran","doi":"10.1155/2023/1933783","DOIUrl":"10.1155/2023/1933783","url":null,"abstract":"<p><strong>Background: </strong>Perindopril is an ACE inhibitor that aids in both blood pressure regulation and homocysteine reduction.</p><p><strong>Objectives: </strong>Our study aimed to evaluate the results of controlling blood pressure and blood homocysteine levels by perindopril in patients with primary hypertension.</p><p><strong>Materials and methods: </strong>A cross-sectional descriptive study with a longitudinal follow-up was conducted on 105 primary hypertensive patients treated with perindopril.</p><p><strong>Results: </strong>The results of our study showed that after 6 weeks of treatment with perindopril, the proportion of patients with the target blood pressure (BP) level accounted for 70.5%, the rate of grade 1 hypertension decreased from 61.0% to 25.7%, grade 2 blood pressure decreased from 17.1% to 3.8%, and there was no case of grade 3 hypertension. At the same time, we also found that the rate of BP control in the group of patients who controlled Hcy below a threshold of 15 <i>μ</i>mol/L was significantly higher than in the other group (<i>p</i>  <  0.05). Concerning the efficacy of decreasing homocysteine in blood, we discovered that after 6 weeks of treatment with perindopril, the proportion of patients with elevated homocysteine reduced considerably from 74.3% to 40% (<i>p</i>  <  0.05). In addition, the homocysteine concentration was 4.33 mol/L lower after treatment than before treatment (95% CI: 3.69-4.97) (<i>p</i>  <  0.05).</p><p><strong>Conclusion: </strong>Perindopril helps control blood pressure and reduces blood homocysteine levels in patients with primary hypertension.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"1933783"},"PeriodicalIF":1.9,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54228967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Hypertension and Associated Factors among Residents Aged ≥18 Years in Ganzhou, China: A Cross-Sectional Study. ≥18岁居民高血压患病率及相关因素 在中国赣州的岁月:横断面研究。
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-10-05 eCollection Date: 2023-01-01 DOI: 10.1155/2023/5486139
Junwang Gu, Qi Wang, Wei Qiu, Fen Lin, Chunmei Wu, Ming Hao, Ping Wu

Background: Reliable epidemiologic data on the present burden of hypertension are needed in developing region-specific strategies since previous studies have suggested that China is lagging in risk factor management.

Objective: The study aimed at exploring the prevalence of hypertension and its associated factors among adult residents in Ganzhou, China. Methodology. A multistage, stratified, and cluster random sampling method was used to conduct the cross-sectional survey. The study selected four county-level districts in Ganzhou City, China, as the investigation area. Permanent residents aged ≥18 years who have settled in the area for 6 months or more were selected. A total of 7430 residents were involved in the study. Univariate and multivariate logistic regression analysis was carried out to identify predictors of hypertension.

Results: The prevalence of hypertension in Ganzhou was 28.5%, and the age-standardized prevalence of hypertension was 22.4%. Univariate logistic regression analysis revealed that multiple variables have a statistically significant effect on the prevalence of hypertension. The elderly (odds ratio [95% CI]: 2.791 [2.594-3.004]), men (1.805 [1.583-2.058]), lower educated (0.848 [0.805-0.893]), a family history of hypertension (4.575 [3.900-5.368]), higher body mass index (1.344 [1.215-1.488]), central obesity (1.532 [1.304-1.799]), and less vegetable intake (1.150 [1.023-1.294]) were the major risk factors for hypertension.

Conclusion: Hypertension is a major public health problem in Ganzhou and requires much effort to reduce its prevalence. An effective multifaceted implementation strategy is highly desirable to combat the emerging burden of hypertension.

背景:由于先前的研究表明中国在风险因素管理方面落后,因此在制定针对特定地区的策略时,需要关于当前高血压负担的可靠流行病学数据。目的:了解赣州市成年居民高血压患病率及其相关因素。方法论采用多阶段、分层、整群随机抽样方法进行横断面调查。本研究选取了中国赣州市的四个县级区作为调查区域。年满18岁且在该地区定居6年的永久居民 选择了个月或更长时间。共有7430名居民参与了这项研究。采用单变量和多变量逻辑回归分析来确定高血压的预测因素。结果:赣州市高血压患病率为28.5%,高血压年龄标准化患病率为22.4%。单因素logistic回归分析显示,多变量对高血压患病率有统计学显著影响。老年人(比值比[95%CI]:2.791[2.594-3.004])、男性(1.805[1.583-2.058])、受教育程度较低(0.848[0.805-0.893])、有高血压家族史(4.575[3.900-5.368])、体重指数较高(1.344[1.255-1.488])、中心性肥胖(1.532[1.304-1.799])和蔬菜摄入量较少(1.150[1.023-1.294])是高血压的主要危险因素。结论:高血压是赣州市的一个重大公共卫生问题,需要大力降低其患病率。一个有效的多方面实施战略是非常可取的,以对抗新出现的高血压负担。
{"title":"Prevalence of Hypertension and Associated Factors among Residents Aged ≥18 Years in Ganzhou, China: A Cross-Sectional Study.","authors":"Junwang Gu,&nbsp;Qi Wang,&nbsp;Wei Qiu,&nbsp;Fen Lin,&nbsp;Chunmei Wu,&nbsp;Ming Hao,&nbsp;Ping Wu","doi":"10.1155/2023/5486139","DOIUrl":"10.1155/2023/5486139","url":null,"abstract":"<p><strong>Background: </strong>Reliable epidemiologic data on the present burden of hypertension are needed in developing region-specific strategies since previous studies have suggested that China is lagging in risk factor management.</p><p><strong>Objective: </strong>The study aimed at exploring the prevalence of hypertension and its associated factors among adult residents in Ganzhou, China. <i>Methodology</i>. A multistage, stratified, and cluster random sampling method was used to conduct the cross-sectional survey. The study selected four county-level districts in Ganzhou City, China, as the investigation area. Permanent residents aged ≥18 years who have settled in the area for 6 months or more were selected. A total of 7430 residents were involved in the study. Univariate and multivariate logistic regression analysis was carried out to identify predictors of hypertension.</p><p><strong>Results: </strong>The prevalence of hypertension in Ganzhou was 28.5%, and the age-standardized prevalence of hypertension was 22.4%. Univariate logistic regression analysis revealed that multiple variables have a statistically significant effect on the prevalence of hypertension. The elderly (odds ratio [95% CI]: 2.791 [2.594-3.004]), men (1.805 [1.583-2.058]), lower educated (0.848 [0.805-0.893]), a family history of hypertension (4.575 [3.900-5.368]), higher body mass index (1.344 [1.215-1.488]), central obesity (1.532 [1.304-1.799]), and less vegetable intake (1.150 [1.023-1.294]) were the major risk factors for hypertension.</p><p><strong>Conclusion: </strong>Hypertension is a major public health problem in Ganzhou and requires much effort to reduce its prevalence. An effective multifaceted implementation strategy is highly desirable to combat the emerging burden of hypertension.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"5486139"},"PeriodicalIF":1.9,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41235190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Mean Platelet Volume in Children with Hypertension. 高血压儿童平均血小板体积的评估。
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-09-21 eCollection Date: 2023-01-01 DOI: 10.1155/2023/5731260
Ismail Yildiz, Ozgur Kizilca

Background: Childhood hypertension, a disease with increasing prevalence, can lead to severe health problems. With the increased pressure on the vascular endothelium in hypertension, lesions in the endothelium result in endothelial activation and a process of inflammation, which causes platelet activation and in the bone marrow the release of platelet precursor cells into the peripheral blood stream. During inflammation, changes in the number and size of platelets are observed. With the release of platelet precursors into the peripheral blood stream due to platelet activation, an increase in mean platelet volume (MPV) is also seen.

Aim: Our aim in this study is the evaluation of MPV changes in the hemogram of children suffering from hypertension, a condition causing severe cardiovascular problems. Material and Methods. This research is a descriptive retrospective cross-sectional study. It consists of a patient group diagnosed with hypertension and a control group of children presenting for routine check-ups with no diagnosed hypertension. Demographic characteristics, arterial pressure values, and hemogram parameters have been evaluated.

Results: A total of 90 cases were enrolled in the study, including a patient group of 45 cases with hypertension (19 females, 26 males) and a control group of 45 cases (27 females, 18 males). The median age was 15 years in the hypertension group and 13 years in the control group. In the hypertension cases, the thickness of the carotis intima media was statistically significantly greater than in the control group (p < 0.001). Echocardiographic findings (IVSd, LVDd, LVPWd, IVSs, LVDs, LVPWs, and LV mass) were significantly higher in the hypertension group compared to the control group (p < 0.001). A statistically significant difference in platelet count and MPV values between the groups was not found (p = 0.151, p = 0.405, respectively).

Conclusion: While MPV is hypothesized to be higher in hypertensive individuals, there was no statistically significant difference between the hypertensive and non-hypertensive groups in this study.

背景:儿童高血压是一种患病率越来越高的疾病,可导致严重的健康问题。随着高血压患者血管内皮压力的增加,内皮损伤导致内皮活化和炎症过程,从而导致血小板活化,并在骨髓中将血小板前体细胞释放到外周血流中。在炎症过程中,可以观察到血小板数量和大小的变化。由于血小板活化,血小板前体释放到外周血流中,还可以看到平均血小板体积(MPV)的增加。目的:我们在这项研究中的目的是评估患有高血压的儿童血象中MPV的变化,高血压是一种导致严重心血管问题的疾病。材料和方法。本研究为描述性回顾性横断面研究。它由一个被诊断为高血压的患者组和一个对照组的儿童组成,他们接受了常规检查,但没有诊断为高血压。对人口统计学特征、动脉压值和血象参数进行了评估。结果:共有90例患者参与研究,包括45例高血压患者组(19名女性,26名男性)和45例对照组(27名女性,18名男性)。中位年龄为15岁 高血压组的年数和13 对照组为年。在高血压病例中,颈动脉内膜中膜厚度在统计学上显著大于对照组(p p p = 0.151,p = 分别为0.405)。结论:虽然假设高血压患者的MPV较高,但在本研究中,高血压组和非高血压组之间没有统计学上的显著差异。
{"title":"Evaluation of Mean Platelet Volume in Children with Hypertension.","authors":"Ismail Yildiz,&nbsp;Ozgur Kizilca","doi":"10.1155/2023/5731260","DOIUrl":"https://doi.org/10.1155/2023/5731260","url":null,"abstract":"<p><strong>Background: </strong>Childhood hypertension, a disease with increasing prevalence, can lead to severe health problems. With the increased pressure on the vascular endothelium in hypertension, lesions in the endothelium result in endothelial activation and a process of inflammation, which causes platelet activation and in the bone marrow the release of platelet precursor cells into the peripheral blood stream. During inflammation, changes in the number and size of platelets are observed. With the release of platelet precursors into the peripheral blood stream due to platelet activation, an increase in mean platelet volume (MPV) is also seen.</p><p><strong>Aim: </strong>Our aim in this study is the evaluation of MPV changes in the hemogram of children suffering from hypertension, a condition causing severe cardiovascular problems. <i>Material and Methods</i>. This research is a descriptive retrospective cross-sectional study. It consists of a patient group diagnosed with hypertension and a control group of children presenting for routine check-ups with no diagnosed hypertension. Demographic characteristics, arterial pressure values, and hemogram parameters have been evaluated.</p><p><strong>Results: </strong>A total of 90 cases were enrolled in the study, including a patient group of 45 cases with hypertension (19 females, 26 males) and a control group of 45 cases (27 females, 18 males). The median age was 15 years in the hypertension group and 13 years in the control group. In the hypertension cases, the thickness of the carotis intima media was statistically significantly greater than in the control group (<i>p</i> < 0.001). Echocardiographic findings (IVSd, LVDd, LVPWd, IVSs, LVDs, LVPWs, and LV mass) were significantly higher in the hypertension group compared to the control group (<i>p</i> < 0.001). A statistically significant difference in platelet count and MPV values between the groups was not found (<i>p</i> = 0.151, <i>p</i> = 0.405, respectively).</p><p><strong>Conclusion: </strong>While MPV is hypothesized to be higher in hypertensive individuals, there was no statistically significant difference between the hypertensive and non-hypertensive groups in this study.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"5731260"},"PeriodicalIF":1.9,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41124338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans 非洲高血压的药物基因组学:为非洲高血压治疗的药物遗传学方法铺平道路
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-05-30 DOI: 10.1155/2023/9919677
Jonathan N. Katsukunya, Nyarai D. Soko, Jashira Naidoo, Brian Rayner, Dirk Blom, Phumla Sinxadi, Emile R. Chimusa, Michelle Dandara, Kevin Dzobo, Erika Jones, Collet Dandara
In Africa, the burden of hypertension has been rising at an alarming rate for the last two decades and is a major cause for cardiovascular disease (CVD) mortality and morbidity. Hypertension is characterised by elevated blood pressure (BP) ≥ 140/90 mmHg. Current hypertension guidelines recommend the use of antihypertensives belonging to the following classes: calcium channel blockers (CCB), angiotensin converting inhibitors (ACEI), angiotensin receptor blockers (ARB), diuretics, β-blockers, and mineralocorticoid receptor antagonists (MRAs), to manage hypertension. Still, a considerable number of hypertensives in Africa have their BP uncontrolled due to poor drug response and remain at the risk of CVD events. Genetic factors are a major contributing factor, accounting for 20% to 80% of individual variability in therapy and poor response. Poor response to antihypertensive drug therapy is characterised by elevated BPs and occurrence of adverse drug reactions (ADRs). As a result, there have been numerous studies which have examined the role of genetic variation and its influence on antihypertensive drug response. These studies are predominantly carried out in non-African populations, including Europeans and Asians, with few or no Africans participating. It is important to note that the greatest genetic diversity is observed in African populations as well as the highest prevalence of hypertension. As a result, this warrants a need to focus on how genetic variation affects response to therapeutic interventions used to manage hypertension in African populations. In this paper, we discuss the implications of genetic diversity in CYP11B2, GRK4, NEDD4L, NPPA, SCNN1B, UMOD, CYP411, WNK, CYP3A4/5, ACE, ADBR1/2, GNB3, NOS3, B2, BEST3, SLC25A31, LRRC15 genes, and chromosome 12q loci on hypertension susceptibility and response to antihypertensive therapy. We show that African populations are poorly explored genetically, and for the few characterised genes, they exhibit qualitative and quantitative differences in the profile of pharmacogene variants when compared to other ethnic groups. We conclude by proposing prioritization of pharmacogenetics research in Africa and possible adoption of pharmacogenetic-guided therapies for hypertension in African patients. Finally, we outline the implications, challenges, and opportunities these studies present for populations of non-European descent.
在非洲,高血压的负担在过去二十年中以惊人的速度上升,是心血管疾病死亡率和发病率的一个主要原因。高血压的特征是血压升高(BP)≥140/90 mmHg。目前的高血压指南推荐使用以下类别的抗高血压药物:钙通道阻滞剂(CCB)、血管紧张素转换抑制剂(ACEI)、血管紧张素受体阻滞剂(ARB)、利尿剂、β受体阻滞剂和矿化皮质激素受体拮抗剂(MRAs)来控制高血压。尽管如此,非洲仍有相当多的高血压患者由于药物反应不佳,血压未得到控制,仍有发生心血管疾病事件的风险。遗传因素是一个主要的影响因素,占治疗的个体差异和不良反应的20%至80%。降压药物治疗反应差的特点是血压升高和药物不良反应(adr)的发生。因此,已有大量研究检验了遗传变异的作用及其对抗高血压药物反应的影响。这些研究主要是在非非洲人口中进行的,包括欧洲人和亚洲人,很少或没有非洲人参与。值得注意的是,非洲人群的遗传多样性最大,高血压患病率也最高。因此,有必要关注遗传变异如何影响非洲人群对高血压治疗干预措施的反应。在本文中,我们讨论了遗传多样性的CYP11B2、GRK4、NEDD4L、NPPA、SCNN1B、UMOD、CYP411、WNK、CYP3A4/5、ACE、ADBR1/2、GNB3、NOS3、B2、BEST3、SLC25A31、LRRC15基因和染色体12q位点对高血压易感性和抗高血压治疗反应的影响。我们表明,非洲人口在遗传学上的探索很少,对于少数特征基因,与其他种族群体相比,它们在药物基因变异谱中表现出定性和定量差异。最后,我们建议在非洲优先进行药物遗传学研究,并可能采用药物遗传学指导治疗非洲患者的高血压。最后,我们概述了这些研究对非欧洲血统人群的影响、挑战和机遇。
{"title":"Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans","authors":"Jonathan N. Katsukunya, Nyarai D. Soko, Jashira Naidoo, Brian Rayner, Dirk Blom, Phumla Sinxadi, Emile R. Chimusa, Michelle Dandara, Kevin Dzobo, Erika Jones, Collet Dandara","doi":"10.1155/2023/9919677","DOIUrl":"https://doi.org/10.1155/2023/9919677","url":null,"abstract":"In Africa, the burden of hypertension has been rising at an alarming rate for the last two decades and is a major cause for cardiovascular disease (CVD) mortality and morbidity. Hypertension is characterised by elevated blood pressure (BP) ≥ 140/90 mmHg. Current hypertension guidelines recommend the use of antihypertensives belonging to the following classes: calcium channel blockers (CCB), angiotensin converting inhibitors (ACEI), angiotensin receptor blockers (ARB), diuretics, <i>β</i>-blockers, and mineralocorticoid receptor antagonists (MRAs), to manage hypertension. Still, a considerable number of hypertensives in Africa have their BP uncontrolled due to poor drug response and remain at the risk of CVD events. Genetic factors are a major contributing factor, accounting for 20% to 80% of individual variability in therapy and poor response. Poor response to antihypertensive drug therapy is characterised by elevated BPs and occurrence of adverse drug reactions (ADRs). As a result, there have been numerous studies which have examined the role of genetic variation and its influence on antihypertensive drug response. These studies are predominantly carried out in non-African populations, including Europeans and Asians, with few or no Africans participating. It is important to note that the greatest genetic diversity is observed in African populations as well as the highest prevalence of hypertension. As a result, this warrants a need to focus on how genetic variation affects response to therapeutic interventions used to manage hypertension in African populations. In this paper, we discuss the implications of genetic diversity in <i>CYP11B2, GRK4, NEDD4L, NPPA, SCNN1B, UMOD, CYP411, WNK, CYP3A4/5, ACE, ADBR1/2, GNB3, NOS3, B2, BEST3, SLC25A31, LRRC15</i> genes, and chromosome 12q loci on hypertension susceptibility and response to antihypertensive therapy. We show that African populations are poorly explored genetically, and for the few characterised genes, they exhibit qualitative and quantitative differences in the profile of pharmacogene variants when compared to other ethnic groups. We conclude by proposing prioritization of pharmacogenetics research in Africa and possible adoption of pharmacogenetic-guided therapies for hypertension in African patients. Finally, we outline the implications, challenges, and opportunities these studies present for populations of non-European descent.","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138533993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covariates of Knowledge, Attitude, Practice, and Burdens among the Caregivers of Hypertensive Patients. 高血压患者照护者知识、态度、行为与负担的协变量
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/8866231
Sudipta Deb Nath, Afrin Sultana Chowdhury, Susmita Dey Pinky, Kazi Mahmuda Akter, Nishat Anjum Nourin, Tonmoy Chowdhury, Hossain Ahmed Fahid, K M Shailah Sharmin, Md Mashud Rana, Nazmul Alam, Md Moinul Ahsan, Adnan Mannan

Caregivers of hypertensive patients play a significant role in ensuring adequate patient care and lowering the risk of hypertension-relatedcomplications. Caregivers are ideal study subjects for identifying gaps in hypertension management. Our study aimed to assess the knowledge, attitude, and practice (KAP) of hypertensive patients' caregivers, to identify their extent of involvement in patients' care, and to assess their care-related attributes. A descriptive cross-sectional study was conducted from August 2020 to February 2021 in the eight largest tertiary care medical college hospitals and all eight divisions of Bangladesh, with 949 caregivers enrolled. Data were collected using a pretested interviewer-administered questionnaire through snowball sampling and analyzed using a one-way ANOVA, independent-sample T-test, and chi-square test. Among the 949 interviewed caregivers, 541 (57.0%) were female, and 479 (50.5%) were aged 18 to 25 years. The percentage scores regarding overall knowledge, attitude, and practice of the caregivers were 54.83 ± 17.95, 47.95 ± 24.05, and 61.26 ± 17.50, respectively. Caregivers' education, history of hypertension, residence, age, relationship with the patient, occupation, and caregiving duration were significantly associated with the KAP scores. In addition, factors such as relationship with the patient, age, educational status, occupation, residence, and caregiving duration/day had significant correlations with all types of burden. Findings of this study suggest the necessity for awareness programs for the caregivers of hypertensive patients to diminish the gap in their KAP and improve their mental and physical health.

高血压患者的护理人员在确保充分的患者护理和降低高血压相关并发症的风险方面发挥着重要作用。护理人员是确定高血压管理差距的理想研究对象。本研究旨在评估高血压患者照护者的知识、态度和实践(KAP),以确定他们参与患者照护的程度,并评估他们的照护相关属性。从2020年8月至2021年2月,在孟加拉国8所最大的三级医疗学院医院和所有8个部门进行了一项描述性横断面研究,招募了949名护理人员。通过滚雪球抽样,采用预测问卷收集数据,并采用单因素方差分析、独立样本t检验和卡方检验进行分析。949名受访护理人员中,女性541人(57.0%),年龄在18 ~ 25岁的479人(50.5%)。护理人员的总体知识、态度和行为得分分别为54.83±17.95、47.95±24.05和61.26±17.50。护理者的教育程度、高血压史、居住地、年龄、与患者的关系、职业、护理时间与KAP得分显著相关。此外,与患者的关系、年龄、受教育程度、职业、居住地、护理时间/天等因素与各类负担均有显著相关。本研究结果提示,有必要对高血压患者的照护者进行认知活动,以缩小他们在KAP上的差距,改善他们的身心健康。
{"title":"Covariates of Knowledge, Attitude, Practice, and Burdens among the Caregivers of Hypertensive Patients.","authors":"Sudipta Deb Nath,&nbsp;Afrin Sultana Chowdhury,&nbsp;Susmita Dey Pinky,&nbsp;Kazi Mahmuda Akter,&nbsp;Nishat Anjum Nourin,&nbsp;Tonmoy Chowdhury,&nbsp;Hossain Ahmed Fahid,&nbsp;K M Shailah Sharmin,&nbsp;Md Mashud Rana,&nbsp;Nazmul Alam,&nbsp;Md Moinul Ahsan,&nbsp;Adnan Mannan","doi":"10.1155/2023/8866231","DOIUrl":"https://doi.org/10.1155/2023/8866231","url":null,"abstract":"<p><p>Caregivers of hypertensive patients play a significant role in ensuring adequate patient care and lowering the risk of hypertension-relatedcomplications. Caregivers are ideal study subjects for identifying gaps in hypertension management. Our study aimed to assess the knowledge, attitude, and practice (KAP) of hypertensive patients' caregivers, to identify their extent of involvement in patients' care, and to assess their care-related attributes. A descriptive cross-sectional study was conducted from August 2020 to February 2021 in the eight largest tertiary care medical college hospitals and all eight divisions of Bangladesh, with 949 caregivers enrolled. Data were collected using a pretested interviewer-administered questionnaire through snowball sampling and analyzed using a one-way ANOVA, independent-sample <i>T</i>-test, and chi-square test. Among the 949 interviewed caregivers, 541 (57.0%) were female, and 479 (50.5%) were aged 18 to 25 years. The percentage scores regarding overall knowledge, attitude, and practice of the caregivers were 54.83 ± 17.95, 47.95 ± 24.05, and 61.26 ± 17.50, respectively. Caregivers' education, history of hypertension, residence, age, relationship with the patient, occupation, and caregiving duration were significantly associated with the KAP scores. In addition, factors such as relationship with the patient, age, educational status, occupation, residence, and caregiving duration/day had significant correlations with all types of burden. Findings of this study suggest the necessity for awareness programs for the caregivers of hypertensive patients to diminish the gap in their KAP and improve their mental and physical health.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"8866231"},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10111522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Association between Hemoglobin Concentration and Blood Pressure in Adults: A Cross-Sectional Study Based on Rafsanjan Cohort Study. 成人血红蛋白浓度与血压正相关:基于拉夫桑詹队列研究的横断面研究。
IF 1.9 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/6283711
Gholamreza Bazmandegan, Mitra Abbasifard, Hamid Ostadebrahimi, Mohammadreza Gholamrezapour, Zahra Kamiab

Introduction: Identification of factors associated with blood pressure (BP), including hemoglobin, can be used in diagnosing, controlling, and predicting the prognosis of patients. This study aims to investigate the cross-sectional association between hemoglobin concentration and BP in people aged 35-70 years in a cohort study of Rafsanjan, Iran.

Method: This cross-sectional study was conducted on 9398 urban and rural population of Rafsanjan adult cohort study as a part of the prospective epidemiological research studies in Iran (PERSIAN). Demographic information, medical history, history of smoking and alcohol intake, systolic and diastolic BP, and hemoglobin concentration were collected. A logistic regression test was performed to evaluate the relationship between hemoglobin concentration and BP in 4 unadjusted and adjusted models based on demographic indicators, clinical and laboratory findings using SPSS.24 software and SAS software version 9.2.

Results: The mean age of the participants was 49.78 ± 9.53 years, and 53.2% (5002 people) were women. Adjusted models 3 and 4 showed a positive association between BP and hemoglobin. For each unit increase in hemoglobin, the odds ratio (OR) of BP in the adjusted model 3 was 1.062 (95% CI: 1.005-1.121), and in the adjusted model 4, it was 1.090 (95% CI: 1.031-1.153).

Conclusion: Based on the results, the positive trend of BP and hemoglobin levels may indicate the need to pay more attention to these people as higher-risk groups for hypertension.

前言:识别与血压(BP)相关的因素,包括血红蛋白,可用于诊断、控制和预测患者的预后。在伊朗拉夫桑詹的一项队列研究中,本研究旨在调查35-70岁人群中血红蛋白浓度与血压之间的横断面关联。方法:对伊朗(波斯)地区拉夫桑詹成人队列研究的9398名城乡人口进行横断面研究,作为前瞻性流行病学研究的一部分。收集患者的人口统计信息、病史、吸烟和饮酒史、收缩压和舒张压、血红蛋白浓度。采用SPSS.24软件和SAS软件9.2版本,基于人口学指标、临床和实验室结果,对4个未调整和调整模型的血红蛋白浓度与血压的关系进行logistic回归检验。结果:参与者的平均年龄为49.78±9.53岁,女性占53.2%(5002人)。调整后的模型3和模型4显示血压与血红蛋白呈正相关。每单位血红蛋白升高,调整模型3中BP的比值比(OR)为1.062 (95% CI: 1.005-1.121),调整模型4为1.090 (95% CI: 1.031-1.153)。结论:综上所述,血压和血红蛋白水平呈上升趋势,提示需要对这些人群作为高血压的高危人群给予更多的关注。
{"title":"Positive Association between Hemoglobin Concentration and Blood Pressure in Adults: A Cross-Sectional Study Based on Rafsanjan Cohort Study.","authors":"Gholamreza Bazmandegan,&nbsp;Mitra Abbasifard,&nbsp;Hamid Ostadebrahimi,&nbsp;Mohammadreza Gholamrezapour,&nbsp;Zahra Kamiab","doi":"10.1155/2023/6283711","DOIUrl":"https://doi.org/10.1155/2023/6283711","url":null,"abstract":"<p><strong>Introduction: </strong>Identification of factors associated with blood pressure (BP), including hemoglobin, can be used in diagnosing, controlling, and predicting the prognosis of patients. This study aims to investigate the cross-sectional association between hemoglobin concentration and BP in people aged 35-70 years in a cohort study of Rafsanjan, Iran.</p><p><strong>Method: </strong>This cross-sectional study was conducted on 9398 urban and rural population of Rafsanjan adult cohort study as a part of the prospective epidemiological research studies in Iran (PERSIAN). Demographic information, medical history, history of smoking and alcohol intake, systolic and diastolic BP, and hemoglobin concentration were collected. A logistic regression test was performed to evaluate the relationship between hemoglobin concentration and BP in 4 unadjusted and adjusted models based on demographic indicators, clinical and laboratory findings using SPSS.24 software and SAS software version 9.2.</p><p><strong>Results: </strong>The mean age of the participants was 49.78 ± 9.53 years, and 53.2% (5002 people) were women. Adjusted models 3 and 4 showed a positive association between BP and hemoglobin. For each unit increase in hemoglobin, the odds ratio (OR) of BP in the adjusted model 3 was 1.062 (95% CI: 1.005-1.121), and in the adjusted model 4, it was 1.090 (95% CI: 1.031-1.153).</p><p><strong>Conclusion: </strong>Based on the results, the positive trend of BP and hemoglobin levels may indicate the need to pay more attention to these people as higher-risk groups for hypertension.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2023 ","pages":"6283711"},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9275266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
International Journal of Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1